Professional Documents
Culture Documents
Reddy - Betapharm
• Distribution
– Highly fragmented market and Unorganized sector
– Reduce the efforts needed to establish (Identification,
Promotion, Incentives)
– Reduce SG&A cost
• Manufacturing
– The manufacturing cost in India is 50% less than the global
average
– Source Betapharm’s business from India to reduce the
COGS
• Pipeline
– R&D costs can be reduced considerably (around 35%)
– Number of products launched per year would increase
Synergy
• Branding
– Brand Beta
– Global Presence
• Presence
– Entry into Germany
– Central & Eastern Europe
• Size
– DRL was able to reach the $1Billion size due to this
acquisition
– Leverage its generic business to grow in Drug
discovery
Integration
Post Merger Integration
• Management of Control
• Execution Challenges